The Analog-to-Digital Converter (ADC) is a key component in digital communications receive channels, and the correct choice of ADC is critical for optimizing system design. In this article, we discuss ...

Keymed Biosciences Inc., a biotech company focused on the urgent unmet clinical needs, announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) developed by Keymed, received Investigational ...

About PF-08052666 (HBM9033) PF-08052666 is an ADC drug that targets human MSLN, a tumor-associated antigen (TAA) upregulated in various solid tumors. The fully human monoclonal antibody (mAb) in ...

LAUSANNE, Switzerland, April 28, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today ...

Superb internalization profile paired with proprietary linker technology underscore strong efficacy and optimal stability data; first-in-class ADC program currently in IND-enabling studies ...

A Bay Area pro­tein de­sign start­up wants to build more po­tent an­ti­body-drug con­ju­gates, and is start­ing with $20 mil­lion in seed fund­ing.

The company has established one of the world's leading proprietary ADC platforms, OptiDC™, and has 1 ADC project approved for marketing, 1 ADC project in NDA stage, and multiple ADC or novel ADC ...

The ODT-ADS-7B64G-3 is an ultra-high-bandwidth time-interleaved ADC designed in a 3nm CMOS process. This 7-bit, 64GSPS ADC supports ac-coupled input signals up to Nyquist and features a full-scale ...